Comparison of BD Multivisc with the soft shell technique in cases with hard lens nucleus and Fuchs endothelial dystrophy

Eur J Ophthalmol. 2007 Sep-Oct;17(5):709-13. doi: 10.1177/112067210701700504.

Abstract

Purpose: To compare the efficacy of 2.5% sodium hyaluronate (BD Multivisc) with the soft shell technique in reducing corneal endothelial cell damage during cataract phacoemulsification in patients with hard lens nucleus (3+) and cornea guttata.

Methods: Thirty patients (37 eyes) scheduled for cataract surgery at Department of Ophthalmology and Visual Sciences, University Hospital San Raffaele, Milano, Italy. Thirty-seven eyes (randomly divided into Groups A and B) with hard lens nucleus (grade 3 or higher) and cornea guttata had phacoemulsification using the soft shell technique (Group A) with Biolon (sodium hyaluronate 1%) and Viscoat (sodium hyaluronate 3%-chondroitin sulfate 4%) or with BD Multivisc alone (Group B). Patients were evaluated preoperatively and after 1, 15, 90, and 180 days, checked for best-corrected visual acuity (BCVA), intraocular pressure (IOP), central corneal thickness, and corneal endothelial density. Stop and chop phacoemulsification technique, with burst mode (Alcon Legacy 20000, Advantec), was performed.

Results: There were no significant differences between the two groups at 3 and 6 months in BCVA, IOP, corneal thickness, or endothelial cell density. The increase of central corneal thickness (preoperative: Group A 584+/-30 microm, Group B 573+/-30 microm; postoperative at 90 days: Group A 593+/-38 microm, Group B 577+/-25 microm) was not significant. Endothelial cell loss was similar in both groups.

Conclusions: The results suggest that the soft shell technique (Biolon, Viscoat) and 2.5% sodium hyaluronate (BD Multivisc) are both effective in protecting the corneal endothelium in Fuchs dystrophy during phacoemulsification in patients with hard lens nucleus.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Anterior Chamber
  • Cataract / complications
  • Cataract / pathology*
  • Corneal Diseases / prevention & control*
  • Endothelium, Corneal / drug effects
  • Follow-Up Studies
  • Fuchs' Endothelial Dystrophy / complications*
  • Fuchs' Endothelial Dystrophy / pathology
  • Humans
  • Hyaluronic Acid / administration & dosage*
  • Lens Nucleus, Crystalline / pathology*
  • Lenses, Intraocular
  • Phacoemulsification / methods*
  • Treatment Outcome
  • Visual Acuity

Substances

  • Hyaluronic Acid